Article
FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
13 Sept 2011
Abstract excerpt
PURPOSE: Integrated genomics approaches have revealed at least four distinct biologic variants of medulloblastoma: WNT (wingless), SHH (sonic hedgehog), group C, and group D. Because of the remarkable clinical heterogeneity of group D tumors and the dismal prognosis of group C patients, it is vital to identify molecular biomarkers that will allow early and effective treatment stratification in these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
